Managed Care Cast

Heard at ASH 2021: Payers and RWE in CAR T-Cell Therapy

12.28.2021 - By Managed Care CastPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

With key data presented at this year’s 63rd Annual American Society of Hematology Meeting and Exposition showing several CAR T-cell therapies as effective and safe options in the second- and even first-line setting for multiple myeloma and other cancers, discussions on when to best to use these therapies in the real-world setting has garnered increasing attention by payers and providers.

At ASH 2021, we sat down with several key opinion leaders to discuss the use of real-world data for CAR T-cell therapies and its importance in influencing reimbursement and investment strategies by payers.

More episodes from Managed Care Cast